These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 24391945)

  • 1. Heterogeneous persister cells formation in Acinetobacter baumannii.
    Barth VC; Rodrigues BÁ; Bonatto GD; Gallo SW; Pagnussatti VE; Ferreira CA; de Oliveira SD
    PLoS One; 2013; 8(12):e84361. PubMed ID: 24391945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of polymyxin B and meropenem eradicates persister cells from Acinetobacter baumannii strains in exponential growth.
    Gallo SW; Ferreira CAS; de Oliveira SD
    J Med Microbiol; 2017 Aug; 66(8):1257-1260. PubMed ID: 28721845
    [No Abstract]   [Full Text] [Related]  

  • 3. Combination of colistin and tobramycin inhibits persistence of Acinetobacter baumannii by membrane hyperpolarization and down-regulation of efflux pumps.
    Kashyap S; Kaur S; Sharma P; Capalash N
    Microbes Infect; 2021; 23(4-5):104795. PubMed ID: 33567337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determining the Development of Persisters in Extensively Drug-Resistant Acinetobacter baumannii upon Exposure to Polymyxin B-Based Antibiotic Combinations Using Flow Cytometry.
    Wong FH; Cai Y; Leck H; Lim TP; Teo JQ; Lee W; Koh TH; Tan TT; Tan KW; Kwa AL
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31818819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel decoy strategy for polymyxin resistance in
    Park J; Kim M; Shin B; Kang M; Yang J; Lee TK; Park W
    Elife; 2021 Jun; 10():. PubMed ID: 34180396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Characteristics of persister cells and the diversity of type II toxin - antitoxin system in Acinetobacter baumannii].
    Ma Y; Zhu Y; Li W; Liu F; Lv N; Li J; Zhu B; Hu Y
    Wei Sheng Wu Xue Bao; 2015 Jul; 55(7):949-58. PubMed ID: 26710614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levels of persisters influenced by aeration in Acinetobacter calcoaceticus-baumannii.
    Donamore BK; Gallo SW; Abreu Ferreira PM; Sanchez Ferreira CA; de Oliveira SD
    Future Microbiol; 2018 Feb; 13():209-219. PubMed ID: 29302999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-walled spherical
    Zou J; Kou SH; Xie R; VanNieuwenhze MS; Qu J; Peng B; Zheng J
    Emerg Microbes Infect; 2020 Dec; 9(1):1149-1159. PubMed ID: 32419626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eradication of persister cells of Acinetobacter baumannii through combination of colistin and amikacin antibiotics.
    Chung ES; Ko KS
    J Antimicrob Chemother; 2019 May; 74(5):1277-1283. PubMed ID: 30759206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paradoxical Effect of Polymyxin B: High Drug Exposure Amplifies Resistance in Acinetobacter baumannii.
    Tsuji BT; Landersdorfer CB; Lenhard JR; Cheah SE; Thamlikitkul V; Rao GG; Holden PN; Forrest A; Bulitta JB; Nation RL; Li J
    Antimicrob Agents Chemother; 2016 Jul; 60(7):3913-20. PubMed ID: 27067330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinically relevant concentrations of fosfomycin combined with polymyxin B, tobramycin or ciprofloxacin enhance bacterial killing of Pseudomonas aeruginosa, but do not suppress the emergence of fosfomycin resistance.
    Walsh CC; Landersdorfer CB; McIntosh MP; Peleg AY; Hirsch EB; Kirkpatrick CM; Bergen PJ
    J Antimicrob Chemother; 2016 Aug; 71(8):2218-29. PubMed ID: 27118778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro pharmacodynamics of polymyxin B and tigecycline alone and in combination against carbapenem-resistant Acinetobacter baumannii.
    Hagihara M; Housman ST; Nicolau DP; Kuti JL
    Antimicrob Agents Chemother; 2014; 58(2):874-9. PubMed ID: 24277022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hetero- and adaptive resistance to polymyxin B in OXA-23-producing carbapenem-resistant Acinetobacter baumannii isolates.
    Barin J; Martins AF; Heineck BL; Barth AL; Zavascki AP
    Ann Clin Microbiol Antimicrob; 2013 Jul; 12():15. PubMed ID: 23819554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aminoglycoside Heteroresistance in Acinetobacter baumannii AB5075.
    Anderson SE; Sherman EX; Weiss DS; Rather PN
    mSphere; 2018 Aug; 3(4):. PubMed ID: 30111627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid killing of Acinetobacter baumannii by polymyxins is mediated by a hydroxyl radical death pathway.
    Sampson TR; Liu X; Schroeder MR; Kraft CS; Burd EM; Weiss DS
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5642-9. PubMed ID: 22908157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymyxin B in combination with doripenem against heteroresistant Acinetobacter baumannii: pharmacodynamics of new dosing strategies.
    Rao GG; Ly NS; Bulitta JB; Soon RL; San Roman MD; Holden PN; Landersdorfer CB; Nation RL; Li J; Forrest A; Tsuji BT
    J Antimicrob Chemother; 2016 Nov; 71(11):3148-3156. PubMed ID: 27494922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of meropenem exposure in persister cells of Acinetobacter calcoaceticus-baumannii.
    Gallo SW; Donamore BK; Pagnussatti VE; Ferreira CA; de Oliveira SD
    Future Microbiol; 2017 Feb; 12():131-140. PubMed ID: 28111984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combinatorial pharmacodynamics of polymyxin B and tigecycline against heteroresistant Acinetobacter baumannii.
    Rao GG; Ly NS; Diep J; Forrest A; Bulitta JB; Holden PN; Nation RL; Li J; Tsuji BT
    Int J Antimicrob Agents; 2016 Sep; 48(3):331-6. PubMed ID: 27449542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro double and triple synergistic activities of Polymyxin B, imipenem, and rifampin against multidrug-resistant Acinetobacter baumannii.
    Yoon J; Urban C; Terzian C; Mariano N; Rahal JJ
    Antimicrob Agents Chemother; 2004 Mar; 48(3):753-7. PubMed ID: 14982760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro evaluation of the antimicrobial activity of meropenem in combination with polymyxin B and gatifloxacin against Pseudomonas aeruginosa and Acinetobacter baumannii.
    Guelfi KC; Tognim MC; Cardoso CL; Gales AC; Carrara-Marrone FE; Garcia LB
    J Chemother; 2008 Apr; 20(2):180-5. PubMed ID: 18467243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.